96 reports

Students are also demonstrated the examination of gastrointestinal endoscopy.

  • Healthcare
  • Managed Care
  • Medical Education
  • World
  • Market Size

Opioid Receptor Antagonists- Pipeline Insight, 2018 Executive Summary Overview Opioids Types of Opioid Receptors Opioid Receptor Antagonists in Dermatology Opioid Receptor Antagonists in Gastrointestinal Diseases Opioid Receptor Antagonists in Central Nervous System Pipeline Therapeutics (A

  • Opioid
  • Therapy
  • CURRENT DRUG CLASSES USED FOR POST-OPERATIVE PAIN
  • 1.4 TREATMENT OPTIONS FOR PAIN

Pain is defined as an unpleasant feeling brought on by a noxious stimuli or injury. The expression of pain can drive someone to stay away from harmful situations, defend injured tissues and avoid similar situations in future. Usually pain is classified as either acute or chronic, and can also be classified into mild, moderate and severe on...

  • Opioid
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Purdue Pharma L.P.

We are one of the nation' s Top ## health systems.

  • Managed Care
  • Opioid
  • United States
  • Supply
  • GlobalData's company

(USA) ##.

  • Analgesic
  • Opioid
  • Therapy
  • United States
  • Market Shares

Non-steroidal anti-inflammatory drugs were mainly developed to reduce NSAID-induced gastrointestinal toxicity.

  • Opioid
  • Market Size
  • BioDelivery Sciences International, Inc.
  • ProStrakan Group plc
  • Teva Pharmaceuticals Ltd.
  • 07. Disease Overview

Drivers and their Impact Hospitals Low Low ## ## ## ## ## High High Impact on Key Customer Category Driver Low Pharmacies High ## ## ## ## ## Increase in Patient Population Improved Diagnosis Patient Assistance Programs ## ## ## ## ## Low Low ## ## ## ## ## High High ## ## ## ##

  • Opioid
  • AstraZeneca PLC
  • Sucampo Pharmaceuticals, Inc.
  • Takeda Pharmaceutical Company Limited
  • Valeant Pharmaceuticals International, Inc.
  • 10.2 ABBREVIATIONS
  • 2.1 CATALYST

The usage of opioids and their adverse effects in gastrointestinal practice: a review.

  • Opioid
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Progenics Pharmaceuticals, Inc.
  • Salix Pharmaceuticals, Ltd.

The company' s digestive health products include diagnostics and therapeutics, gastrointestinal endoscopy products, enteral feeding tubes and accessories.

  • Respiratory Monitoring
  • Eastern Europe
  • Russia
  • Forecast
  • CareFusion Corporation

Moreover, these narcoticsare used in the treatment of irritable bowel syndrome-induced diarrhea since they act on gastrointestinal receptors.

  • Opioid
  • Therapy
  • North America
  • United States
  • Forecast
  • INTELLECTUAL PROPERTY
  • RECALL AND GENERICS HURT DURAGESIC

INHIBITION OF COX--## IS ASSOCIATED WITH THE WELL--KNOWN GASTROINTESTINAL BLEEDING THAT THE DESIRED ANTI--INFLAMMATORY EFFECTS OF NSAIDS ARE LARGELY DUE TO INHIBITION OF COX--##.

  • Managed Care
  • Opioid
  • United States
  • Bedrocan Canada Inc.
  • Medical Marijuana, Inc.
  • TAPEMARK

By avoiding the gastrointestinal system, the drug is less likely to cause nausea.

  • Opioid
  • Generex Biotechnology Corporation
  • Nitto Denko Corporation
  • Noven Pharmaceuticals, Inc.
  • Teva Pharmaceutical Industries Ltd.

Drivers and their Impact Impact on End-user Category Driver Expiry of Patents Increased Investment in Healthcare Infrastructure Hospitals Low Low ## ## ## ## ## High Low Pharmaceutical Stores High ## ## ## ## ## High Low High ## ## ## ## ## ## ## ## ## ## Cost Factor Increase in Elde

  • Anti-Infective
  • Opioid
  • Japan
  • Meiji Seika Pharma Co., Ltd.
  • Nipro Corporation

The prominent features of this report are - ##.

  • Chronic Disease
  • Clinical Trial
  • Diabetes
  • Opioid
  • World
  • Clinical Trial profile. 71 Trial Title
  • Clinical Trial profile. 130 Trial Title

The prominent features of this report are - ##.

  • Clinical Trial
  • Digestive System Disorder
  • Opioid
  • World
  • Merck & Co., Inc.
  • US Hydromorphone Market: By value - Forecast: 2014F-2019F (in US$ million)
  • 4.5 The US Hydrocodone Market: Size and Growth

Types of Chronic Pain ##.

  • Opioid
  • United States
  • Egalet Corporation
  • Pfizer Inc.
  • Zogenix, Inc.
  • Clinical Trial profile. 223 Trial Title
  • Clinical Trial profile. 563 Trial Title

The prominent features of this report are - ##.

  • Drug Discovery And Development
  • Opioid
  • Pharmaceutical
  • World
  • Product Initiative
  • OSTEOPOROSIS, BREAST CANCER PREVENTION
  • 6. PRODUCT PROFILES

THIS ALSO REDUCES THE RISKS OF SIDE EFFECTS IN GASTROINTESTINAL TRACT.

  • Opioid
  • North America
  • United States
  • Demand
  • Market Size
  • SMALL MOLECULE TO ANTAGONIZE MU OPIOID RECEPTOR FOR GASTROINTESTINAL DISORDERS - DRUG PROFILE
  • Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Overview

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H1 2017, provides an overview of the Opioid-Induced Bowel Dysfunction (OBD or OIBD) (Toxicology)...

  • Opioid
  • Therapy
  • Turkey
  • United States
  • World
  • Opioid-Induced Constipation (OIC) - Pipeline by Sucampo Pharmaceuticals Inc, H2 2017
  • Opioid-Induced Constipation (OIC) - Pipeline by Synergy Pharmaceuticals Inc, H2 2017

These medicines affect the gastrointestinal tract in a variety of ways.

  • Gastrointestinal Drug
  • Opioid
  • United States
  • World
  • Product Initiative
  • SMALL MOLECULE TO ANTAGONIZE MU OPIOID RECEPTOR FOR GASTROINTESTINAL DISORDERS - DRUG PROFILE
  • OPIOID-INDUCED BOWEL DYSFUNCTION (OBD OR OIBD) - PIPELINE BY CHIRONWELLS GMBH, H2 2016

Opioid-Induced Bowel Dysfunction (OBD or OIBD) - Pipeline Review, H2 2016 Summary Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Opioid-Induced Bowel Dysfunction – Pipeline Review, H2 2016, provides an overview of the Opioid-Induced Bowel Dysfunction (Toxicology) pipeline landscape. Opioid-induced...

  • Opioid
  • Turkey
  • United States
  • World
  • Product Initiative
  • Opioid-Induced Constipation (OIC) - Companies Involved in Therapeutics Development
  • Opioid-Induced Constipation (OIC) - Pipeline by Sucampo Pharmaceuticals Inc, H1 2018

These medicines affect the gastrointestinal tract in a variety of ways.

  • Digestive System Disorder
  • Gastrointestinal Drug
  • Opioid
  • United States
  • Product Initiative

Colace®Capsules is the number one doctor recommended stool softener brand.

  • Managed Care
  • Opioid
  • Respiratory Monitoring
  • United States
  • Purdue Pharma L.P.

Ethypharm SA (Ethypharm), a subsidiary of Astorg Partners is a pharmaceutical company that develops and manufactures drugs for the treatment of pain, gastrointestinal, cancer, cardiovascular and central nervous system diseases.

  • Managed Care
  • Opioid
  • Pharmaceutical
  • United States
  • Camurus

The debentures bear an interest rate of ##% per annum payable monthly, and will mature on January ##, 2015.

  • Opioid
  • Pharmaceutical
  • United States
  • Corporate Finance
  • Intellipharmaceutics International Inc.

Medicare Part D, ESI (PBM) has also added Zubsolv to the preferred formulary position effective January ##, 2018.

  • Opioid
  • Pharmaceutical
  • United States
  • Company Financials
  • Orexo US Inc.

Representative of Rhode Island, founder of The Kennedy Forum, and co-founder of One Mind.

  • Opioid
  • Pharmaceutical
  • United States
  • Company
  • Braeburn Pharmaceuticals, Inc.

It provides medicines for pain, respiratory disease, urinary incontinence, attention deficit hyperactivity disorder, gastrointestinal disorders, psychiatry, neurology, infection control and others.

  • Managed Care
  • Opioid
  • United States
  • Company Financials
  • BioDelivery Sciences International, Inc.
  • FRESENIUS MEDICAL CARE AG & CO KGAA, DEALS BY THERAPY AREA, 2012 TO YTD 2018

DIALYSIS TREATMENTS INCREASED BY ##%.

  • Managed Care
  • Opioid
  • Australia
  • Company Financials
  • Fresenius Group

Interest on notes will be paid semi-annually in arrears on April ## and October ## of each year, beginning on October ##, 2017.

  • Managed Care
  • Opioid
  • United States
  • Company Financials
  • Pacira Pharmaceuticals, Inc.